Vincristine (VCR) is a vinca alkaloid and common chemotherapeutic that is used to treat multiple pediatric and adult malignancies. Despite its common use, cases of anaphylaxis to VCR are rare and typically isolated to a single individual. We report a series of eight patients with adverse reactions to VCR over the course of 11 months at a single institution, four of which progressed to anaphylaxis and one of which resulted in cardiac arrest. Mass spectrometry analysis of medication lots was performed to test for possible contaminant(s). Our findings highlight the risk of anaphylaxis during therapy with VCR.
INTRODUCTION
Vincristine (VCR) is a vinca alkaloid that was historically purified from the Madagascar periwinkle Catharanthus roseus, but is now synthesized. 1,2 VCR is a common chemotherapeutic that is used to treat multiple pediatric and adult malignancies. Cases of anaphylaxis to VCR have been reported, but are rare and typically isolated to a single individual. 3, 4 Between July 2015 and May 2016, eight patients had symptoms of adverse reactions immediately after receiving VCR at The Children's Hospital of Philadelphia (CHOP), and similar reactions were colloquially reported at other institutions around the country. A subset of the patients treated at CHOP (four of eight) progressed to anaphylaxis.
We performed a manual chart review of the electronic medical records for these patients, as well as mass spectrometry (MS) analysis of medication lots, to determine the cause of the reactions. This study was Abbreviations: CHOP, The Children's Hospital of Philadelphia; MS, mass spectrometry; VCR, vincristine reviewed by the CHOP Institutional Review Board and determined to be exempt from requiring approval.
RESULTS
The demographic and clinical characteristics of the patients are shown in Table 1 . There were five male and three female patients, with an average age of 5 years. Patients were treated with three lots of VCR from two different manufacturers. Underlying oncologic diagnoses were acute lymphoblastic leukemia, vaginal sarcoma, oligodendroglioma, medulloblastoma, lymphoblastic lymphoma, and Wilm's tumor. On review, we found no obvious change in the medication administration protocol, equipment associated with the medication infusion, or other similarity among the patients in question (other medications, underlying diagnosis, etc.) that would explain the reac- Symptoms experienced were immediate and included respiratory (100%), vomiting (50%), flushing (25%), hypotension (25%), mouth itch (13%), headache (13%), and cardiac arrest (13%) ( Table 1 ). While two patients experienced flushing, no patients experienced hives. Patients required therapy with antihistamines (100%), intravenous fluids (75%), steroids (50%), epinephrine (50%), supplemental oxygen (25%), and albuterol (13%) ( Table 1) . Reactions occurred on first exposure to VCR in two of the eight patients. Seven of the patients were treated with VCR subsequently without reaction, and four of these received premedications (anti-histamines ± steroids) prior to subsequent infusions.
One patient required no further VCR due to completion of therapy (patient number 4). There were no long-term, medically related negative sequelae of these reactions. The spectra and analysis of the control and experimental VCR samples are presented in Figure 1 and Supplementary Table S1 . Most of the molecules in both the control and experimental preparations were VCR in either mono-or diprotonated forms ( Fig. 1 and Supplementary Table S1 , peaks V1 and V2). Tandem MS analysis confirmed the identity of these molecules as VCR ( Supplementary Fig. S1 ). We also identified three molecules present at up to 7% relative abundance in the experimental sample, and reduced or near absent in the control sample ( Fig. 1 and Supplementary Table S1 , peaks , , and ). Tandem MS analysis revealed common product ions between these peaks and VCR, indicating that these molecules were likely related to the vinca alkaloids ( Supplementary Fig. S1 ) Table S1 , peak ). The composition of peak relative to VCR was not able to be predicted.
DISCUSSION
VCR is a chemotherapeutic that is used to treat multiple pediatric and adult malignancies. Because of its common use, it is essential to understand the risks of adverse reactions with this medication. Although cases of anaphylaxis to VCR have been reported, they are rare and typically isolated to a single individual. 3, 4 We report a series of eight adverse reactions to VCR, four of which progressed to anaphylaxis.
It is thought that most drugs are too small to directly illicit an IgE-dependent immune response. Rather, they act as haptens or prohaptens by binding endogenous proteins and causing an IgEmediated reaction. Alternatively, small molecules can lead to direct, IgE-independent mast cell activation, complement activation, and/or kallikrein activation. 9 It is therefore possible that seemingly subtle differences in molecular composition can result in dramatically different immune reactivity.
We cannot be certain that the identified molecules in our study were the etiology of the observed reactions, and we do not know the mechanism of the reactions in our population. While MS is a very sensitive technique for identification of compounds, it is not without limitations and can have difficulty identifying nonvolatile and very rare substances, as well as compounds not currently available in spectra databases. 10, 11 Furthermore, very small amounts of allergen can elicit clinically significant reactions making identification of the causal compound difficult.
Nevertheless, the frequency and characteristics of the reactions reviewed here are mostly consistent with a reaction to a contaminant.
It is possible that the contaminants identified represent degradation products. However, VCR concentrate is stable for 24 months when stored appropriately, and 7 days once diluted. All doses administered in this case series strictly adhered to these recommended time periods. As such, we favor a contaminant resulting from the manufactur- approved the final version to be published, and agree to be accountable for all aspects of the work including accuracy and integrity.
